Back to top

Tvardi Therapeutics (TVRD) Receives a Hold from Cantor Fitzgerald

Cantor Fitzgerald analyst maintained a Hold rating on Tvardi Therapeutics yesterday. The company’s shares closed yesterday at $1.88. Currently, the...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Tvardi Therapeutics, Inc. (TVRD)